canSAR: update to the cancer translational research and drug discovery knowledgebase

被引:37
|
作者
Coker, Elizabeth A. [1 ,3 ]
Mitsopoulos, Costas [2 ]
Tym, Joesph E. [1 ]
Komianou, Angeliki [1 ]
Kannas, Christos [1 ]
Di Micco, Patrizio [1 ]
Fernandez, Eloy Villasclaras [1 ]
Ozer, Bugra [1 ,2 ]
Antolin, Albert A. [1 ]
Workman, Paul [2 ]
Al-Lazikani, Bissan [1 ,2 ]
机构
[1] Inst Canc Res, Dept Data Sci, London SM2 5NG, England
[2] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SM2 5NG, England
[3] Wellcome Trust Sanger Inst, Translat Canc Genom, Hinxton, England
关键词
D O I
10.1093/nar/gky1129
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
canSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal druggability' assessments. canSAR is widely used internationally by academia and industry. Here we describe major enhancements to canSAR including new and expanded data. We also describe the first components of canSARblackan advanced, responsive, multi-device compatible redesign of canSAR with a question-led interface.
引用
收藏
页码:D917 / D922
页数:6
相关论文
共 50 条
  • [1] canSAR: update to the cancer translational research and drug discovery knowledgebase
    di Micco, Patrizio
    Antolin, Albert A.
    Mitsopoulos, Costas
    Villasclaras-Fernandez, Eloy
    Sanfelice, Domenico
    Dolciami, Daniela
    Ramagiri, Pradeep
    Mica, Ioan L.
    Tym, Joseph E.
    Gingrich, Philip W.
    Hu, Huabin
    Workman, Paul
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2023, 51 (D1) : D1212 - D1219
  • [2] canSAR: update to the cancer translational research and drug discovery knowledgebase
    Mitsopoulos, Costas
    Di Micco, Patrizio
    Fernandez, Eloy Villasclaras
    Dolciami, Daniela
    Holt, Esty
    Mica, Ioan L.
    Coker, Elizabeth A.
    Tym, Joseph E.
    Campbell, James
    Che, Ka Hing
    Ozer, Bugra
    Kannas, Christos
    Antolin, Albert A.
    Workman, Paul
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2021, 49 (D1) : D1074 - D1082
  • [3] canSAR, a cancer research and drug discovery knowledgebase
    Coker, Elizabeth A.
    Di Micco, Patrizio
    Tym, Joesph E.
    Mitsopoulos, Costas
    Komianou, Angeliki
    Antolin, Albert A.
    Al-Lazikani, Bissan
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] canSAR: an updated cancer research and drug discovery knowledgebase
    Tym, Joseph E.
    Mitsopoulos, Costas
    Coker, Elizabeth A.
    Razaz, Parisa
    Schierz, Amanda C.
    Antolin, Albert A.
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2016, 44 (D1) : D938 - D943
  • [5] canSAR: updated cancer research and drug discovery knowledgebase
    Bulusu, Krishna C.
    Tym, Joseph E.
    Coker, Elizabeth A.
    Schierz, Amanda C.
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) : D1040 - D1047
  • [6] canSAR: an integrated cancer public translational research and drug discovery resource
    Halling-Brown, Mark D.
    Bulusu, Krishna C.
    Patel, Mishal
    Tym, Joe E.
    Al-Lazikani, Bissan
    [J]. NUCLEIC ACIDS RESEARCH, 2012, 40 (D1) : D947 - D956
  • [7] The canSAR data hub for drug discovery
    Chau, Cindy H.
    O'Keefe, Barry R.
    Figg, William D.
    [J]. LANCET ONCOLOGY, 2016, 17 (03): : 286 - 286
  • [8] Translational research for lung cancer - An update
    Nishio, K
    Korfee, S
    Eberhardt, W
    Saijo, N
    Tamura, T
    [J]. PROCEEDINGS OF THE 9TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2004, : 45 - 47
  • [9] Translational research: the changing landscape of drug discovery
    Fishburn, C. Simone
    [J]. DRUG DISCOVERY TODAY, 2013, 18 (9-10) : 487 - 494
  • [10] Translational research: Drug discovery from the inside
    Derek Lowe
    [J]. Nature Chemical Biology, 2015, 11 (4) : 239 - 239